EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Two Decades of Molecular Surveillance in Kenya Reveal Shifting Plasmodium falciparum Drug Resistance Mutations Linked to Frontline Drug Changes

George A Tollefson, Benjamin H Opot, Titus Kipkemboi Maina, Dennis W Juma, Raphael O Okoth, Jackline A Juma, Gladys Chemwor, Edwin W Mwakio, Abebe A Fola, John M Onge'cha, Bernhards R Ogutu, Rebecca M Crudale und 2 weitere

The American Journal of Tropical Medicine and Hygiene · 06.11.2026

DOI: 10.4269/ajtmh.25-0513 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, erschienen am 06.11.2026. Verfasst von George A Tollefson und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USA. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria control has faced repeated challenges due to the emergence and spread of antimalarial resistance. In the present study, temporal trends in Plasmodium falciparum resistance mutations were analyzed using molecular inversion probe sequencing of 625 samples from 11 Kenyan sites (1998–2021), spanning multiple frontline treatments. After the phased adoption of artemether–lumefantrine as first-line treatment of uncomplicated malaria in 2006, a rapid increase in multidrug resistance protein 1 N86 and D1246 alleles associated with reduced lumefantrine susceptibility was observed, along with an accelerated decline in the chloroquine resistance transporter CVIET haplotype associated with chloroquine and amodiaquine resistance. Sulfadoxine–pyrimethamine (SP) resistance mutations (dihydrofolate reductase [DHFR] 51I, 59R, 108N; dihydropteroate synthase 437G, 540E) reached near-fixation after the introduction of SP as the first-line therapy for uncomplicated malaria in 1998 and persisted at near-fixation through 2021. The high-level pyrimethamine resistance mutation DHFR 164L emerged and expanded after 2012. Furthermore, mutations associated with reduced artemisinin efficacy were identified in ubiquitin-specific protease 1, adaptor protein complex 2, mu subunit, and sarcoplasmic/endoplasmic reticulum calcium adenosine triphosphatase. Although no validated kelch13 (K13) artemisinin partial resistance mutations were detected, several novel K13 propeller domain missense mutations, including 473F and 569S, were observed after the adoption of artemisinin-based combination therapies. These findings reveal the rapid, dynamic evolution of drug resistance in the context of shifting antimalarial drug pressures and underscore the need for sustained genomic surveillance in malaria-endemic regions to inform adaptive treatment strategies. The persistence of SP resistance and the emergence of markers associated with reduced susceptibility to artemisinins and partner drugs raise concerns about the long-term efficacy of current antimalarials for treatment, seasonal malaria chemoprevention, and intermittent preventive interventions.

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USA.
  • Center for Computational Molecular Biology, Brown University, Providence, Rhode Island, USA.
  • Kenya Medical Research Institute/Walter Reed Army Institute of Research, Africa, Kisumu, Kenya.
  • Kenya Medical Research Institute, Kisumu and Nairobi, Kenya.

Zitieren

APA

Tollefson, G. A., Opot, B. H., Maina, T. K., Juma, D. W., Okoth, R. O., Juma, J. A., Chemwor, G., Mwakio, E. W., Fola, A. A., Onge'cha, J. M., Ogutu, B. R., Crudale, R. M., Bailey, J. A., & Akala, H. M. (2026). Two Decades of Molecular Surveillance in Kenya Reveal Shifting Plasmodium falciparum Drug Resistance Mutations Linked to Frontline Drug Changes. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.25-0513

Vancouver

Tollefson GA, Opot BH, Maina TK, Juma DW, Okoth RO, Juma JA, et al. Two Decades of Molecular Surveillance in Kenya Reveal Shifting Plasmodium falciparum Drug Resistance Mutations Linked to Frontline Drug Changes. The American Journal of Tropical Medicine and Hygiene. 2026. doi:10.4269/ajtmh.25-0513

BibTeX
@article{Tollefson2026,
  author = {Tollefson, George A and Opot, Benjamin H and Maina, Titus Kipkemboi and Juma, Dennis W and Okoth, Raphael O and Juma, Jackline A and Chemwor, Gladys and Mwakio, Edwin W and Fola, Abebe A and Onge'cha, John M and Ogutu, Bernhards R and Crudale, Rebecca M and Bailey, Jeffrey A and Akala, Hoseah M},
  title = {Two Decades of Molecular Surveillance in Kenya Reveal Shifting Plasmodium falciparum Drug Resistance Mutations Linked to Frontline Drug Changes},
  journal = {The American Journal of Tropical Medicine and Hygiene},
  year = {2026},
  doi = {10.4269/ajtmh.25-0513}
}
Kostenlos starten →